Testing effectiveness (Phase 2)Active Not RecruitingNCT07725432
What this trial is testing
Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation
Who this might be right for
Immune-related Vitiligo-like-Depigmentation
University of Zurich 34